Injections of botulinum toxin to treat blepharospasm, hemifacial spasm, and certain types of strabismus.
Botulinum toxin (Botox, Dysport, Xeomin) injections weaken overactive muscles by blocking nerve signals. In neuro-ophthalmology, it's used to treat involuntary muscle spasms and certain eye movement disorders.
Key Takeaways
- Weakens overactive muscles
- First-line treatment for blepharospasm and hemifacial spasm
- Effects last 3-4 months
- Repeat injections needed
- High success rate with minimal side effects
Common Uses
- Blepharospasm
- Hemifacial spasm
- Strabismus (eye misalignment)
- Protective ptosis (intentional lid drooping)
What to Expect
Before Injection
- Review medical history
- Discuss previous responses
- May need to stop blood thinners
During Injection
- Small needle used
- Multiple injection points around eyes
- Mild discomfort (brief pinch)
- Takes 10-15 minutes
- No anesthesia usually needed
After Injection
- Resume normal activities immediately
- Avoid rubbing injection sites for hours
- Effects start in 2-5 days
- Peak effect at 1-2 weeks
How Well It Works
Blepharospasm
- 90%+ improvement
- Significant quality of life benefit
Hemifacial Spasm
- 85-95% improvement
- May reduce spasms dramatically
Side Effects
Common (Temporary)
- Bruising at injection sites
- Mild ptosis (droopy eyelid)
- Dry eye
- Tearing
Less Common
- Weakness of nearby muscles
- Difficulty closing eye
- Blurred vision (temporary)
Duration
- Side effects temporary (weeks)
- Resolve as toxin wears off
Repeat Treatments
- Effects last approximately 3-4 months
- Regular injections needed for ongoing control
- Dose may be adjusted based on response
- Some develop tolerance (rare)
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice.
Medically Reviewed Content
This article meets our editorial standards
- Written by:
- Hashemi Eye Care Medical Team
- Medically reviewed by:
- Board-Certified Neuro-Ophthalmologist (MD, Neuro-Ophthalmology)
- Last reviewed:
- January 30, 2025
